LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | -66.7% | 835 | -87.6% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 6,742 | -2.6% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 6,921 | +20.7% | 0.00% | – |
| Q2 2022 | $4,000 | +33.3% | 5,735 | +108.5% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 2,751 | -25.9% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 3,712 | +103.5% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 1,824 | +15.9% | 0.00% | – |
| Q1 2021 | $5,000 | – | 1,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 166,667 | $124,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 99,644 | $74,000 | 0.05% |
| Almanack Investment Partners, LLC. | 248,084 | $185,000 | 0.02% |
| Warberg Asset Management LLC | 14,500 | $11,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 16,948 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 49 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 25,794 | $19,000 | 0.00% |
| STATE STREET CORP | 35,956 | $28,000 | 0.00% |
| MORGAN STANLEY | 71,054 | $53,000 | 0.00% |
| Citadel Advisors | 30,063 | $23,000 | 0.00% |